
GRDC and partners invest $11m into CSIRO mouse management research
Research into mouse activity and the threat it presents to Australian grain growers will be boosted by a new $11 million joint investment.
The multi-million dollar investment from the Grains Research & Development Corporation and partners will fund research led by the CSIRO, allowing multi-year collaborative projects to continue.
The research, conducted by the CSIRO, is aimed at forming impact mitigation strategies by investigating how food availability and habitat quality for mice can be reduced through different farming practices as well as lowering breeding success and survival.
It also looks at the effectiveness of baiting strategies, novel bait formulations, the use of non-lethal deterrents, the impact of non-crop habitats, and the role of invertebrates in supporting the rapid population growth of mice.
GRDC pest manager Dr Leigh Nelson said that advancements in farming systems provided more cover, more food and less ground disturbance from reduced tillage for mice, which had encouraged a population boom.
'Over the years, GRDC initiatives have improved mouse surveillance techniques, refined predictive models, and promoted the widespread adoption of effective management practices through robust communication and extension activities,' she said.
'We will continue to work with key research partners such as CSIRO to tackle the challenges posed by mice to grain production through investments like those announced.'
Mouse activity will be monitored three times a year at more than 200 sites across the country, to provide region-specific data.
Research on mouse ecology and gaining a better understanding of mice in zero and no-till cropping systems will be led by senior research scientist Dr Wendy Ruscoe.
'The more we know about mouse behaviour in these systems, the more we can help grain growers reduce their economic impact through leading crop protection practice and mouse management techniques,' she said.
A GRDC mouse monitoring update released on May 5 showed a low amount of mouse abundance from the Mid West to the south coast, and a moderate mouse abundance in areas in the Mid West and Great Southern.
CSIRO research scientist Dr Peter Brown will lead ongoing monitoring of mice to predict seasonal population outbreaks throughout cropping regions including the South West, Great Southern, Mid West, and Esperance-Goldfields.
'This comprehensive portfolio of research will deliver grain growers the latest evidence-backed information on how to reduce the impact of mice in crops,' Dr Brown said.
Mice surveillance will also take place in South Australia, Victoria, New South Wales, and Queensland.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Perth Now
10 hours ago
- Perth Now
‘Overwhelmed': Major virus breakthrough
Australian researchers have found a way to force the HIV virus out of hiding within cells, opening the way to eradicate the virus from the body. The human immunodeficiency virus is able to hide within white blood cells, presenting a serious roadblock for scientists pursuing a cure. Research from Melbourne's Peter Doherty Institute for Infection and Immunity, published in late-May, says work towards a cure is one step closer. The next hurdle is analysing whether revealing the virus allows the body's immune system to fight off the virus or if additional treatments need to be combined. Australian researchers are closer to a HIV cure. Credit: News Limited 'In terms of specifically the field of HIV cure, we have never seen anything close to as good as what we are seeing in terms of how well we are able to reveal this virus,' co-author Paula Cevaal told the Guardian. 'We were overwhelmed by how night-and-day difference it was – from not working before, and then all of a sudden it was working. And all of us were just sitting gasping like, 'Wow'.' The HIV that hides in white blood cells can reactivate. The Peter Doherty Institute researchers used custom-made fat bubbles to deliver mRNA into cells where HIV is hiding. The mRNA tells the cells to reveal the virus. Messenger RNA is a molecule that contains instructions for cells to make a protein. The technology rose to prominence during the Covid-19 pandemic. People with HIV have to take medication for their entire life to suppress the virus, avoid symptoms and to stop transmission to other people. About 30,000 Australians live with HIV. In 2023, 722 new cases were reported to health authorities. Globally, in 2023, an estimated 500,000 to 820,000 people died from HIV-related causes.


West Australian
10 hours ago
- West Australian
‘Overwhelmed': Major breakthrough from Aussie researchers in HIV study
Australian researchers have found a way to force the HIV virus out of hiding within cells, opening the way to eradicate the virus from the body. The human immunodeficiency virus is able to hide within white blood cells, presenting a serious roadblock for scientists pursuing a cure. Research from Melbourne's Peter Doherty Institute for Infection and Immunity, published in late-May, says work towards a cure is one step closer. The next hurdle is analysing whether revealing the virus allows the body's immune system to fight off the virus or if additional treatments need to be combined. 'In terms of specifically the field of HIV cure, we have never seen anything close to as good as what we are seeing in terms of how well we are able to reveal this virus,' co-author Paula Cevaal told the Guardian. 'We were overwhelmed by how night-and-day difference it was – from not working before, and then all of a sudden it was working. And all of us were just sitting gasping like, 'Wow'.' The HIV that hides in white blood cells can reactivate. The Peter Doherty Institute researchers used custom-made fat bubbles to deliver mRNA into cells where HIV is hiding. The mRNA tells the cells to reveal the virus. Messenger RNA is a molecule that contains instructions for cells to make a protein. The technology rose to prominence during the Covid-19 pandemic. People with HIV have to take medication for their entire life to suppress the virus, avoid symptoms and to stop transmission to other people. About 30,000 Australians live with HIV. In 2023, 722 new cases were reported to health authorities. Globally, in 2023, an estimated 500,000 to 820,000 people died from HIV-related causes.


7NEWS
a day ago
- 7NEWS
Australian breakthrough blood test offers hope for early ovarian cancer detection
An Australian developed blood test for cancer is being hailed as a potential lifesaver for thousands of women, with promising results unveiled at a major international medical conference. In a groundbreaking announcement at the American Society of Clinical Oncology (ASCO) conference in the United States, Australian scientists revealed the revolutionary blood test can detect ovarian cancer in its earliest-and most treatable-stages. Developed in a Melbourne laboratory, the INNOVIQ EXO-OC™ Test has shown remarkable accuracy in trials. Its key highlights include: 77 per cent sensitivity at 99.6 per cent specificity for detecting ovarian cancer across all stages, surpassing globally accepted clinical performance criteria for population screening. Detected all early-stage cancers (Stage I and II) with no missed diagnoses-a critical advancement in addressing the unmet need for accurate and reliable early detection in asymptomatic, average-risk women. 'This will be a world-first,' Dr Leearne Hinch, the CEO of the company told 7NEWS. 'Our test will enable many women's lives to be saved globally.' Professor Greg Rice, from the University of Queensland, who played a key role in the development of the test, confirmed the breakthrough. 'In the most recent tests that we completed, the EXO-OC™ test correctly identified all early stage ovarian cancers,' he told 7NEWS. Ovarian cancer is often called the 'silent killer' as it is usually asymptomatic in the early stages of disease. For women like Emily Jol, the test could have made a life-changing difference. It took six months for her to receive a diagnosis after being told an ovarian cyst found during a routine ultrasound was 'completely normal.' 'There was nothing wrong with it, they said. It was just part of being a woman,' Emily recalled to 7NEWS. Just 21-years-old at the time, she continued to push for answers and eventually, surgery revealed the truth: she had ovarian cancer. Fortunately, it was caught before it spread. 'I still consider myself to be really, really lucky,' she said. That's a rare outcome as currently, most ovarian cancer cases are diagnosed too late. One Australian woman dies from the disease every eight hours. Because it's often diagnosed at a late stage, after symptoms have appeared, the survival rate beyond five years can be as little as 30 per cent. But with the new test, scientists believe that survival rate could soar to over 90 percent. 'We're very proud that this is Australian science,' said Dr Hinch. The test is still undergoing further evaluation, but if all goes well, it could receive regulatory, FDA, approval in the United States soon, and hit the global market within two to three years. A message of hope where little existed before. It was partly funded by the Ovarian Cancer Research Foundation.